Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03516981 |
|---|---|
| Brief Title: | A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) |
| First Submitted : | April 27, 2018 |
| First Submitted that Met QC Criteria : | April 27, 2018 |
| First Posted : | May 7, 2018 |
| Last Update Submitted that Met QC Criteria : | August 23, 2022 |
| Last Update Posted : | August 26, 2022 |